RU2017136047A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017136047A3 RU2017136047A3 RU2017136047A RU2017136047A RU2017136047A3 RU 2017136047 A3 RU2017136047 A3 RU 2017136047A3 RU 2017136047 A RU2017136047 A RU 2017136047A RU 2017136047 A RU2017136047 A RU 2017136047A RU 2017136047 A3 RU2017136047 A3 RU 2017136047A3
- Authority
- RU
- Russia
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2017136047A RU2697411C2 (en) | 2017-10-11 | 2017-10-11 | Composition for treating parkinson's disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2017136047A RU2697411C2 (en) | 2017-10-11 | 2017-10-11 | Composition for treating parkinson's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017136047A RU2017136047A (en) | 2019-04-11 |
| RU2017136047A3 true RU2017136047A3 (en) | 2019-04-11 |
| RU2697411C2 RU2697411C2 (en) | 2019-08-14 |
Family
ID=66167982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017136047A RU2697411C2 (en) | 2017-10-11 | 2017-10-11 | Composition for treating parkinson's disease |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2697411C2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115707462A (en) * | 2021-08-19 | 2023-02-21 | 沈阳药科大学 | Levodopa composition for improving brain targeting and application thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4610868A (en) * | 1984-03-20 | 1986-09-09 | The Liposome Company, Inc. | Lipid matrix carriers for use in drug delivery systems |
| US5229130A (en) * | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
| ATE428371T1 (en) * | 1998-07-17 | 2009-05-15 | Pacira Pharmaceuticals Inc | BIODEGRADABLE ARRANGEMENTS FOR THE CONTROLLED RELEASE OF ENCLOSED SUBSTANCES |
| US6376545B1 (en) * | 1998-11-10 | 2002-04-23 | Teva Pharmaceutical Industries, Ltd. | Dispersible compositions containing L-DOPA ethyl ester |
| WO2003041646A2 (en) * | 2001-11-13 | 2003-05-22 | Teva Pharmaceutical Industries, Ltd. | L-dopa ethyl ester salts and uses thereof |
| US7160913B2 (en) * | 2002-09-13 | 2007-01-09 | Thomas Jefferson University | Methods and kit for treating Parkinson's disease |
| JP2008534563A (en) * | 2005-03-28 | 2008-08-28 | オレクソ・アクチエボラゲット | New pharmaceutical compositions useful for the treatment of Parkinson's disease |
| RU2545734C1 (en) * | 2014-01-31 | 2015-04-10 | Открытое акционерное общество "Всероссийский Научный Центр Молекулярной Диагностики и Лечения" (ОАО "ВНЦМДЛ) | Drug preparation for parkinson disease |
-
2017
- 2017-10-11 RU RU2017136047A patent/RU2697411C2/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115707462A (en) * | 2021-08-19 | 2023-02-21 | 沈阳药科大学 | Levodopa composition for improving brain targeting and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2697411C2 (en) | 2019-08-14 |
| RU2017136047A (en) | 2019-04-11 |